[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100445382":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":24,"centralContacts":28,"locations":37,"responsibleParty":88,"collaborators":90,"id":94,"slug":95,"hasResults":96,"nctId":97,"briefTitle":98,"officialTitle":99,"acronym":10,"eligibilityCriteria":100,"healthyVolunteers":101,"sex":102,"minAge":103,"maxAge":10,"enrollmentInfo":104,"targetDuration":10,"studyType":107,"phases":10,"briefSummary":108,"conditions":109,"keywords":111,"overallStatus":40,"whyStopped":10,"lastUpdateSubmitDate":113,"lastUpdatePostDateStruct":114,"startDateStruct":117,"completionDateStruct":119,"leadSponsor":121,"locationsCount":122},{"fullName":5,"class":6},"Uniformed Services University of the Health Sciences","FED",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Symptomatic for vaginal yeast",null,"Women presenting to the clinic with symptoms of vulvovaginal candidiasis.",[13],"Device: SavvyCheck Vaginal Yeast Test (rapid, point-of-care diagnostic test)",{"label":15,"type":10,"description":16,"interventionNames":17},"Asymptomatic for vaginal yeast","Women presenting to the clinic with no symptoms of vulvovaginal candidiasis.",[13],[19],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":10},"DEVICE","SavvyCheck Vaginal Yeast Test (rapid, point-of-care diagnostic test)","The SavvyCheck Vaginal Yeast Test is a lateral flow immunochromatographic qualitative test for detection of Candida antigen in vaginal secretions, sampled by a swab as an aid for identification of vulvovaginal candidiasis (VVC), as a primary cause of vaginal yeast infections. The SavvyCheck Vaginal Yeast Test is designed for use by women experiencing vaginal symptoms, including: increased vaginal discharge, vaginal itching, vaginal soreness and irritation, rash on the labia, and genital burning that may worsen during urination. The SavvyCheck Vaginal Yeast Test is indicated for OTC use.",[15,9],[25],{"name":26,"affiliation":5,"role":27},"Elizabeth A Kostas-Polston, PhD","PRINCIPAL_INVESTIGATOR",[29,33],{"name":26,"role":30,"phone":31,"phoneExt":10,"email":32},"CONTACT","301.295.1531","elizabeth.kostas-polston@usuhs.edu",{"name":34,"role":30,"phone":35,"phoneExt":10,"email":36},"Mary B Engler, PhD","301.295.3427","mary.engler@usuhs.edu",[38,57,73],{"facility":39,"status":40,"city":41,"state":42,"zip":43,"country":44,"countryCode":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"Womack Army Medical Center","RECRUITING","Fort Bragg","North Carolina","28310","United States","US",{"type":47,"coordinates":48},"Point",[49,50],-79.00603,35.139,{"lat":50,"lon":49},[53],{"name":54,"role":30,"phone":55,"phoneExt":10,"email":56},"Zach A Delabastide, PA","910-907-7089","zach.a.delabastide.mil@army.mil",{"facility":58,"status":59,"city":60,"state":61,"zip":62,"country":44,"countryCode":45,"cosmosGeoPoint":63,"geoPoint":67,"contacts":68},"Brooke Army Medical Center","NOT_YET_RECRUITING","Fort Sam Houston","Texas","78234",{"type":47,"coordinates":64},[65,66],-98.4417,29.45303,{"lat":66,"lon":65},[69],{"name":70,"role":30,"phone":71,"phoneExt":10,"email":72},"Nicholas R Teneyuque, MD","210-916-2168","nicholas.r.teneyuque.civ@health.mil",{"facility":74,"status":40,"city":75,"state":10,"zip":10,"country":76,"countryCode":77,"cosmosGeoPoint":78,"geoPoint":82,"contacts":83},"Landstuhl Regional Medical Center","Landstuhl","Germany","DE",{"type":47,"coordinates":79},[80,81],7.57021,49.41306,{"lat":81,"lon":80},[84],{"name":85,"role":30,"phone":86,"phoneExt":10,"email":87},"Daniel S Queen, FNP","+49 6371 9464 5462","daniel.s.queen.mil@health.mil",{"type":89,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[91],{"name":92,"class":93},"Savvyon Diagnostics Ltd.","UNKNOWN","100445382","comparative-performance-of-a-vaginal-yeast-test-100445382",false,"NCT05079711","Comparative Performance of a Vaginal Yeast Test","Comparative Performance of the SavvyCheck Vaginal Yeast Test Versus Culture","Inclusion Criteria:\n\nSymptomatic Women Symptomatic women include those women who present with a complaint consistent with symptoms of vaginitis (e.g., increased vaginal discharge, vaginal itching, vaginal soreness and irritation, rash on the labia, and genital burning that may worsen during urination). Enrollment will continue at each clinical site until our target number of 216 Reference Method (vaginal Candida yeast culture) positives have been collected. We estimate up to 600 symptomatic women will be enrolled to meet our target.\n\nInclusion Criteria for Symptomatic Women\n\n1. DoD Military Health System beneficiary\n2. Have a healthcare appointment at a recruitment clinic\n3. 18 years of age or older\n4. Must speak and understand English\n5. Able to provide informed consent\n6. Women experiencing vaginal symptoms, including: increased discharge, itching, soreness and irritation, rash on the labia, and genital burning that may worsen during urination\n7. Must determine the test is applicable to her based on her symptoms after she has read the outside device labeling (box label)\n\nAsymptomatic Women Asymptomatic women include those women who do not present with a complaint consistent with vaginitis. Enrollment will continue at each clinical site until our target number of 170 Reference Method (vaginal Candida yeast culture) negatives have been collected. We estimate up to 320 asymptomatic women will be enrolled to meet our target.\n\nInclusion Criteria for Asymptomatic Women:\n\n1. DoD Military Health System beneficiary\n2. Have a healthcare appointment at a recruitment clinic\n3. 18 years of age or older\n4. Must speak and understand English\n5. Able to provide informed consent\n6. Healthy women appearing for routine care without symptoms of vaginal yeast infection\n\nExclusion Criteria:\n\nIf any of the following criteria are met, a potential subject will be excluded from the study:\n\n1. Currently menstruating\n2. History of any clinical therapies and\u002For interventions related to gender confirmation (transgender person)\n3. Use of any vaginal medication, taken by mouth or vaginally, within the last 7 days\n4. Use of any vaginal product within 24 hours, including contraception (cream, gel, or foam), or douching solutions\n\nNOTE: Women who currently have an intrauterine device (IUD) placed are eligible to participate",true,"FEMALE","18 Years",{"count":105,"type":106},1200,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to establish lay user performance criteria for the SavvyCheck Vaginal Yeast Test in comparison to standard vaginal yeast culture and identification method for Candida (the Reference Method). Polymerase chain reaction (PCR) and sequencing of fungi will be used as an aid to explain the nature of the discrepancy in the case of discordant results between the lay user-performed SavvyCheck Vaginal Yeast Test and standard vaginal yeast culture and identification method for Candida.",[110],"Vulvovaginal Candidiasis",[112],"Vaginal candidiasis, Vaginal yeast culture","2024-05-14",{"date":115,"type":116},"2024-05-16","ACTUAL",{"date":118,"type":116},"2022-03-18",{"date":120,"type":106},"2026-08-30",{"name":5,"class":6},3]